Sort
27,075 grants matching “cholesterol”
Randomized Trial of CVD Education and Problem-Solving Training in Urban Diabetics
$731,222Felicia Hill-Briggs · Johns Hopkins University · R01 · FY2009 · HL
Koli: A non-surgical solution for gallstone disease
$731,133Christopher Cheng · Koli, Inc. · R44 · FY2023 · DK
Sleep and Cardiometabolic Health Disparities at the US/Mexico Border: The Nogales Cardiometabolic Health and Sleep (NoCHeS) Study
$731,043Michael A Grandner · University Of Arizona · R01 · FY2020 · MD
Low CV Risk, Ages 25-44 & CV/non-CV Outcomes, Ages 65+
$730,870Martha L Daviglus · Northwestern University At Chicago · R01 · FY2009 · HL
Structure and Function of Non-Conventional Caveolins
$730,858Anne K Kenworthy · University Of Virginia · R01 · FY2023 · HL
Femoral Plaque Composition, Oxidative Stress, and Coronary Events
$730,733Mary McGrae McDermott · Northwestern University At Chicago · R01 · FY2012 · HL
Using genetic variation to study biology of blood lipids & coronary heart disease
$730,677Gina Marie Peloso · Boston University Medical Campus · R01 · FY2024 · HL
Thromboregulation in Occlusive Vascular Diseases
$730,605Aaron J. Marcus · Weill Medical Coll Of Cornell Univ · R01 · FY2009 · HL
Novel pathogenic mechanism of HIV-associated CNS neurological disorders
$730,589Michael Ilya Bukrinsky · George Washington University · R01 · FY2021 · NS
VISCERAL ADIPOSITY AND CVD RISK IN WOMEN
$730,463Children'S Hospital Med Ctr (Cincinnati) · R01 · FY2003 · HL
An Interpersonal Relationships Intervention for Improving Cardiovascular Health in Youth
$730,456Edith Chen · Northwestern University · R01 · FY2021 · HL
Immigrant enclaves: Conferring health advantages or creating health disparities in Chinese immigrants?
$730,452Carolyn Y Fang · Research Inst Of Fox Chase Can Ctr · R01 · FY2021 · MD
A Neurosteroid Intervention for Menopausal and Perimenopausal Depression
$730,442E Sherwood Brown · Ut Southwestern Medical Center · R01 · FY2018 · AG
Vitamin D and Vascular Function in Obese Children
$730,411Kumaravel Rajakumar · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · HL
Targeting the gut-liver axis in cardiovascular disease
$730,352Thomas A Vallim · University Of California Los Angeles · R01 · FY2024 · HL
Polypill strategy for the treatment of patients after acute coronary syndromes - A multicenter randomized controlled trial
$730,276Ambarish Pandey · Ut Southwestern Medical Center · R01 · FY2025 · HL
Center for American Indian and Alaska Native Diabetes Translation Research (CAIANDTR)
$730,000Spero M Manson · University Of Colorado Denver · P30 · FY2023 · DK
EPICARDIAL ADIPOSE TISSUE, OBESITY AND INFLAMMATION IN ATHEROSCLEROSIS
$729,975Devendra K. Agrawal · Creighton University · R01 · FY2015 · HL
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)
$729,903Priscilla Y. Hsue · University Of California, San Francisco · R61 · FY2018 · HL
Sleep and Cardiometabolic Health Disparities at the US/Mexico Border: The Nogales Cardiometabolic Health and Sleep (NoCHeS) Study
$729,884Michael A Grandner · University Of Arizona · R01 · FY2022 · MD
Managing Atherosclerosis by Modulating HDL Function
$729,767M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2018 · HL
Metabolic interactions in the vascular wall: an integrated experimental and computational approach
$729,600Alisa S Morss Clyne · Univ Of Maryland, College Park · R01 · FY2024 · HL
The Impact of Omega three Fatty Acids on Vascular Function and cIMT in HIV
$729,231Christine A Wanke · Tufts University Boston · R01 · FY2011 · HL
Mechanism of action of oligomer-displacing Alzheimer investigation drug, CT1812:Receptor interactions and signaling pathways
$729,226Nicholas John Izzo · Cognition Therapeutics, Inc. · R44 · FY2020 · AG
THE GENETICS AND MULTI-OMICS SPECIMENS CORE (GMSC)
$729,190Carlos Cruchaga · Washington University · U19 · FY2021 · AG